Efficacy and safety of initial five years of adjuvant endocrine therapy in postmenopausal hormone receptor-positive breast cancer: A systematic review and network meta-analysis.

被引：0
|
作者：
Liao, Hao
Zhong, Jianxin
Pei, Wendi
Bin, Shao
Liu, Xiao-Ran
Rugo, Hope S.
Li, Huiping
机构：
[1] Peking Univ, Canc Hosp, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Beijing, Peoples R China
[3] Beijing Canc Hosp, Beijing, Peoples R China
[4] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
[5] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[6] Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
[7] Peking Univ Canc Hosp & Inst, Dept Breast Oncol, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
535
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis
    Zhu Yu
    Xiaojing Guo
    Yicheng Jiang
    Lei Teng
    Jinwu Luo
    Pengfei Wang
    Yunsheng Liang
    Haitian Zhang
    Breast Cancer, 2018, 25 : 8 - 16
  • [22] The postmenopause: adjuvant endocrine therapy at an early stage of hormone receptor-positive breast cancer
    Brucker, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (08) : 847 - 851
  • [23] Delay Discounting and Adjuvant Endocrine Therapy Adherence in Hormone Receptor-Positive Breast Cancer
    Vaughn, Jennifer E.
    Ammerman, Chesley
    Lustberg, Maryam B.
    Bickel, Warren K.
    Stein, Jeffrey S.
    HEALTH PSYCHOLOGY, 2021, 40 (06) : 398 - 407
  • [24] Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men
    Venigalla, Sriram
    Carmona, Ruben
    Guttmann, David M.
    Jain, Varsha
    Freedman, Gary M.
    Clark, Amy S.
    Shabason, Jacob E.
    JAMA ONCOLOGY, 2018, 4 (10)
  • [25] Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review
    S. J. Ioannides
    P. L. Barlow
    J. M. Elwood
    D. Porter
    Breast Cancer Research and Treatment, 2014, 147 : 237 - 248
  • [26] Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review
    Ioannides, S. J.
    Barlow, P. L.
    Elwood, J. M.
    Porter, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) : 237 - 248
  • [27] Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer
    Lippman, Marc
    LANCET ONCOLOGY, 2019, 20 (03): : 312 - 313
  • [28] Concurrent versus sequential adjuvant chemo-endocrine therapy in early stage hormone receptor-positive breast cancer patients: a systematic review and meta-analysis
    Poggio, F.
    Ceppi, M.
    Lambertini, M.
    Bruzzi, P.
    Ugolini, D.
    Bighin, C.
    Levaggi, A.
    Giraudi, S.
    D'alonzo, A.
    Vaglica, M.
    Blondeaux, E.
    Conte, B.
    Sertoli, M. R.
    Pronzato, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast Cancer
    Tevaarwerk, Amye J.
    Wisinski, Kari B.
    O'Regan, Ruth M.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) : 1148 - +
  • [30] What Is the Optimal Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer?
    Tung, Nadine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) : 1391 - 1397
12345